Demonstration of the clathrin- and caveolin-mediated endocytosis at the maternal-fetal barrier in mouse placenta after intravenous administration of gold nanoparticles

Journal of Veterinary Medical Science

Volumn 76, Issue 3, 2014, Pages 377-387

  Rattanapinyopituk, Kasem ^a,b   Shimada, Akinori ^c   Morita, Takehito ^a,b   Sakurai, Masashi ^a,b   Asano, Atsushi ^a   Hasegawa, Tatsuya ^d   Inoue, Kenichiro ^e   Takano, Hirohisa ^f  

^a TOTTORI UNIVERSITY   (Japan)

^b YAMAGUCHI UNIVERSITY   (Japan)

^c AZABU UNIVERSITY   (Japan)

^d YAMANASHI INSTITUTE OF ENVIRONMENTAL SCIENCES   (Japan)

^e INTERNATIONAL UNIVERSITY OF HEALTH AND WELFARE   (Japan)

^f KYOTO UNIVERSITY   (Japan)

Author keywords

Caveolin; Clathrin; Endocytosis; Gold nanoparticles; Placenta

Indexed keywords

CAVEOLIN 1; CLATHRIN; GOLD; METAL NANOPARTICLE;

ANIMAL; DRUG EFFECTS; ELECTRON MICROSCOPY; ENDOCYTOSIS; FEMALE; FETOMATERNAL TRANSFUSION; IMMUNOBLOTTING; IMMUNOHISTOCHEMISTRY; INSTITUTE FOR CANCER RESEARCH MOUSE; INTRAVENOUS DRUG ADMINISTRATION; MASS SPECTROMETRY; METABOLISM; MOUSE; PHYSIOLOGY; PLACENTA; PREGNANCY;

ADMINISTRATION, INTRAVENOUS; ANIMALS; CAVEOLIN 1; CLATHRIN; ENDOCYTOSIS; FEMALE; GOLD; IMMUNOBLOTTING; IMMUNOHISTOCHEMISTRY; MASS SPECTROMETRY; MATERNAL-FETAL EXCHANGE; METAL NANOPARTICLES; MICE; MICE, INBRED ICR; MICROSCOPY, ELECTRON; PLACENTA; PREGNANCY;

EID: 84897497690     PISSN: 09167250     EISSN: 13477439     Source Type: Journal    
DOI: 10.1292/jvms.13-0512     Document Type: Article

References (40)

1. Austin, C. A., Umbreit, T. H., Brown, K. M., Barber, D. S., Dair, B. J., Francke-Carroll, S., Feswick, A., Saint-Louis, M. A., Hikawa, H., Siebein, K. N. and Goering, P. L. 2012. Distribution of silver nanoparticles in pregnant mice and developing embryos. Nanotoxicology 6: 912-922. [Medline] [CrossRef]
2. Balasubramanian, S. K., Jittiwat, J., Manikandan, J., Ong, C., Yu, L. E. and Ong, W. 2010. Biodistribution of gold nanoparticles and gene expression changes in the liver and spleen after intravenous administration in rats. Biomaterials 31: 2034-2042. [Medline] [CrossRef]
3. Byrne, S., Ahenkorah, J., Hottor, B., Lockwood, C. and Ockleford, C. D. 2007. Immuno-electron microscopic localization of caveolin 1 in human placenta. Immunobiology 212: 39-46. [Medline] [CrossRef]
4. Buerki-Thurnherr, T., von Mandach, U. and Wick, P. 2012. Knocking at the door of the unborn child: engineered nanoparticles at the human placental barrier. Swiss. Med. Wkly. 142: w13559. [Medline]
5. Cartwright, L., Poulsen, M. S., Nielsen, H. M., Pojana, G., Knudsen, L. E., Saunders, M. and Rytting, E. 2012. In vitro placental model optimization for nanoparticle transport studies. Int. J. Nanomedicine 7: 497-510. [Medline]
6. Conner, S. D. and Schmid, S. L. 2003. Regulated portals of entry into the cell. Nature 422: 37-44. [Medline] [CrossRef]
7. Danscher, G. 1984. Autometallography. a new technique for light and electron microscopic visualization of metals in biological tissues (gold, silver, metal sulphides). Histochemistry 81: 331-335. [Medline] [CrossRef]
8. Danscher, G. and Stoltenberg, M. 2006. Silver enhancement of quantum dots resulting from (1) metabolism of toxic metals in animals and humans, (2) in vivo, in vitro and immersion created zinc-sulphur/zinc-selenium nanocrystals, (3) metal ions liberated from metal implants and particles. Prog. Histochem. Cytochem. 41: 57-139. [Medline] [CrossRef]
9. Elsaesser, A. and Howard, V. 2012. Toxicology of nanoparticles. Adv. Drug Deliv. Rev. 64: 129-137. [Medline] [CrossRef]
10. Ema, M., Kobayashi, N., Naya, M., Hanai, S. and Nakanishi, J. 2010. Reproductive and developmental toxicity studies of manufactured nanomaterials. Reprod. Toxicol. 30: 343-352. [Medline] [CrossRef]
11. Furukawa, S., Hayashi, S., Usuda, K., Abe, M., Hagio, S. and Ogawa, I. 2011. Toxicological pathology in the rat placenta. J. Toxicol. Pathol. 24: 95-111. [Medline] [CrossRef]
12. Keelan, J. A. 2011. Nanoparticles versus the placenta. Nanotoxicology 6: 263-264.
13. Khan, H. M., Khan, M. Y. and Minhas, L. A. 2011. Histological study of the developing mouse placenta. J. Rawal. Med. Coll. 15: 116-119.
14. Kirby, D. R. S. and Bradbury, S. 1965. The hemo-chorial mouse placenta. Anat. Rec. 152: 279-281. [Medline] [CrossRef]
15. Kulvietis, V., Zalgeviciene, V., Didzipetriene, J. and Rotomskis, R. 2011. Transport of nanoparticles through the placental barrier. Tohoku J. Exp. Med. 225: 225-234. [Medline] [CrossRef]
16. Lambot, N., Lybaert, P., Boom, A., Delogne-Desnoeck, J., Vanbellinghen, A. M., Graff, G., Lebrun, P. and Meuris, S. 2006. Evidence for a clathrin-mediated recycling of albumin in human term placenta. Biol. Reprod. 75: 90-97. [Medline] [CrossRef]
17. Lasagna-Reeves, C., Gonzalez-Romero, D., Barria, M. A., Olmedo, I., Clos, A., Ramanujam, V. M. S., Urayama, A., Vergara, L., Kogan, M. J. and Soto, C. 2010. Bioaccumulation and toxicity of gold nanoparticles after repeated administration in mice. Biochem. Biophys. Res. Commun. 393: 649-655. [Medline] [CrossRef]
18. Le Roy, C. and Wrana, J. L. 2005. Clathrin- and non-clathrinmediated endocytic regulation of cell signalling. Nat. Rev. Mol. Cell Biol. 6: 112-126. [Medline] [CrossRef]
19. Linton, E. A., Rodriguez-Linares, B., Rashid-Doubell, F., Ferguson, D. J. P. and Redman, C. W. G. 2003. Caveolae and caveolin- 1 in human term villous trophoblast. Placenta 24: 745-757. [Medline] [CrossRef]
20. Lyden, T. W., Anderson, C. L. and Robinson, J. M. 2002. The endothelium but not the synctiotrophoblast of human placenta expresses caveolae. Placenta 23: 640-652. [Medline] [CrossRef]
21. McMahon, H. T. and Boucrot, E. 2011. Molecular mechanism and physiological functions of clathrin-mediated endocytosis. Nat. Rev. Mol. Cell Biol. 12: 517-533. [Medline] [CrossRef]
22. Mohanty, S., Anderson, C. L. and Robinson, J. M. 2010. The expression of caveolin-1 and the distribution of caveolae in the murine placenta and yolk sac: parallels to the human placenta. Placenta 31: 144-150. [Medline] [CrossRef]
23. Mousavi, S. A., Malerød, L., Berg, T. and Kjeken, R. 2004. Clathrin-dependent endocytosis. Biochem. J. 377: 1-6. [Medline] [CrossRef]
24. Myllynen, P. K., Loughran, M. J., Howard, C. V., Sormunen, R., Walsh, A. A. and Vähäkangas, K. H. 2008. Kinetics of gold nanoparticles in the human placenta. Reprod. Toxicol. 26: 130-137. [Medline] [CrossRef]
25. Nabi, I. R. and Le, P. U. 2003. Caveolae/raft-dependent endocytosis. J. Cell Biol. 161: 673-677. [Medline] [CrossRef]
26. Naota, M., Shimada, A., Morita, T., Yamamoto, Y., Inoue, K. and Takano, H. 2013. Caveolae-mediated endocytosis of intratracheally instilled gold colloid nanoparticles at the air-blood barrier in mice. Toxicol. Pathol. 41: 487-496. [Medline] [CrossRef]
27. Pelkmans, L. and Helenius, A. 2002. Endocytosis via caveolae. Traffic 3: 311-320. [Medline] [CrossRef]
28. Rothberg, K. G., Heuser, J. E., Donzell, W. C., Ying, Y., Glenney, J. R. and Anderson, R. G. W. 1992. Caveolin, a protein component of caveolae membrane coats. Cell 68: 673-682. [Medline] [CrossRef]
29. Sadauskas, E., Danscher, G. and Stoltenberg, M. 2009. Protracted elimination of gold nanoparticles from mouse liver. Nanomedicine 5: 162-169. [Medline]
30. Sadauskas, E., Wallin, H., Stoltenberg, M., Vogel, U., Doering, P., Larsen, A. and Danscher, G. 2007. Kupffer cells are central in the removal of nanoparticles from the organism. Part. Fibre Toxicol. 4: 10. [Medline] [CrossRef]
31. Sadauskas, E., Jacobsen, N. R., Danscher, G., Stoltenberg, M., Vogel, U., Larsen, A., Kreyling, W. and Wallin, H. 2009. Biodistribution of gold nanoparticles in mouse lung following intratracheal instillation. Chem. Cent. J. 3: 16. [Medline] [CrossRef]
32. Saunders, M. 2009. Transplacental transport of nanomaterials. Wiley Interdiscip. Rev. Nanomed. Nanobiotechnol. 1: 671-684. [Medline] [CrossRef]
33. Semmler-Behnke, M., Kreyling, W. G., Lipka, J., Fertsch, S., Wenk, A., Takenaka, S., Schmid, G. and Brandau, W. 2008. Biodistribution of 1.4- and 18-nm gold particles in rats. Small 4: 2108-2111. [Medline] [CrossRef]
34. Shukla, R., Bansal, V., Chaudhary, M., Basu, A., Bhonde, R. R. and Sastry, M. 2005. Biocompatibility of gold nanoparticles and their endocytotic fate inside the cellular compartment: a microscopic overview. Langmuir 21: 10644-10654. [Medline] [CrossRef]
35. Sonavane, G., Tomoda, K. and Makino, K. 2008. Biodistribution of colloidal gold nanoparticles after intravenous administration: effect of particle size. Colloids Surf. B Biointerfaces 66: 274-280. [Medline] [CrossRef]
36. Sung, J. H., Ji, J. H., Park, J. D., Song, M. Y., Song, K. S., Ryu, H. R., Yoon, J. U., Jeon, K. S., Jeong, J., Han, B. S., Chung, Y. H., Chang, H. K., Lee, J. H., Kim, D. W., Kelman, B. J. and Yu, I. J. 2011. Subchronic inhalation toxicity of gold nanoparticles. Part. Fibre Toxicol. 8: 16. [Medline] [CrossRef]
37. Takata, K., Fujikura, K. and Shin, B. 1997. Ultrastructure of the rodent placental labyrinth: a site of barrier and transport. J. Reprod. Dev. 43: 13-24. [CrossRef]
38. Wick, P., Malek, A., Manser, P., Meili, D., Maeder-Althaus, X., Diener, L., Diener, P., Zisch, A., Krug, H. F. and von Mandach, U. 2010. Barrier capacity of human placenta for nanosized materials. Environ. Health Perspect. 118: 432-436. [Medline] [CrossRef]
39. Yamashita, K., Yoshioka, Y., Higashisaka, K., Mimura, K., Morishita, Y., Nozaki, M., Yoshida, T., Ogura, T., Nabeshi, H., Nagano, K., Abe, Y., Kamada, H., Monobe, Y., Imazawa, T., Aoshima, H., Shishido, K., Kawai, Y., Mayumi, T., Tsunoda, S., Itoh, N., Yoshikawa, T., Yanagihara, I., Saito, S. and Tsutsumi, Y. 2011. Silica and titanium dioxide nanoparticles cause pregnancy complications in mice. Nat. Nanotechnol. 6: 321-328. [Medline] [CrossRef]
40. Yang, W., Peters, J. I. and Williams, R. O. III. 2008. Inhaled nanoparticles-a current review. Int. J. Pharm. 356: 239-247. [Medline] [CrossRef]